BANNOCKBURN, Ill. , Dec. 18, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate site infusion therapy services, will present at the 38th Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2020 . John C.

BANNOCKBURN, Ill. , Nov. 21, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent provider of home and alternate treatment site infusion therapy services, will present at the Bank of America Merrill Lynch 2019 Leveraged Finance Conference on December 3,

National leader in treating bleeding disorders offers personalized, high-quality patient care BANNOCKBURN, Ill. , Nov. 19, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. , the nation’s largest independent provider of home and alternate treatment site infusion therapy services, has been chosen by

BANNOCKBURN, Ill. , Nov. 06, 2019 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (Nasdaq: BIOS), the nation’s largest independent provider of home and alternate site infusion services, today announced financial results for the third quarter ended September 30, 2019 .

BANNOCKBURN, Ill. , Oct. 16, 2019 (GLOBE NEWSWIRE) -- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that the Company will release results for its third quarter ended September 30, 2019 on

BANNOCKBURN, Ill. --(BUSINESS WIRE)--Aug. 29, 2019-- Option Care Health Inc. (NASDAQ: BIOS), the nation’s largest independent national provider of home and alternate site infusion services, today announced that John Rademacher , Chief Executive Officer, will participate in a fireside chat on

Largest Independent Home and Alternate Site Infusion Provider Establishes the Standard of Care Across the United States Through Its Clinical Leadership and Technology-Enabled Patient-Centered Model BANNOCKBURN, Ill. & DENVER --(BUSINESS WIRE)--Aug. 7, 2019-- Option Care Enterprises, Inc.

DENVER , Aug. 02, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the “Company”), the largest independent national provider of infusion and home care management solutions, today announced that its stockholders approved the proposals that are conditions to the proposed merger

DENVER , July 30, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2019 financial results.

DENVER , July 22, 2019 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip"), the largest independent national provider of infusion and home care management solutions, today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co.